article thumbnail

Atlantic Health System’s Morristown Medical Center Tops 5,000 TAVR Procedures

DAIC

Morristown Medical Center’s Gagnon Cardiovascular Institute’s structural heart program recently reported it has reached a significant milestone of performing over 5,000 transcatheter aortic valve replacement (TAVR) procedures, the first in New Jersey and among the first to accomplish this in the United States.

TAVR 105
article thumbnail

SAVR’s Value in the TAVR Era

CardiacWire

Procedure trends certainly suggest that we’ve entered the TAVR era, but a pair of new studies show that surgical aortic valve replacement (SAVR) is a far better option for many younger and healthier patients who are increasingly seen as TAVR candidates. The post SAVR’s Value in the TAVR Era appeared first on Cardiac Wire.

TAVR 69
article thumbnail

Redo-TAVR with balloon-expandable valves: outcomes from a national registry

Cardiology Update

In light of the growing number of patients undergoing transcatheter aortic valve replacement (TAVR), there is an increasing demand for data regarding the management of failed TAVR procedures, including the possibility of a repeat TAVR intervention. vs. 3.5%, p=0.80) between the redo-TAVR and native-TAVR populations.

TAVR 52
article thumbnail

Association Between Polyvascular Disease and Transcatheter Aortic Valve Replacement Outcomes: Insights from the STS/ACC TVT Registry

Circulation: Cardiovascular Interventions

Background:Atherosclerotic cardiovascular disease (ASCVD) is highly prevalent in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement (TAVR). Exposure of interest was PVD. Primary outcome was all-cause mortality.

article thumbnail

New Study Shows Excellent Long-term Survival After SAVR

Society of Thoracic Surgeons - Congenital

The study reviewed 42,586 patients who underwent low-risk isolated SAVR between 2011 and 2019 at 981 different cardiac surgery programs across the U.S. The study matched the criterion used in the current low-risk trials evaluating SAVR with transcatheter aortic valve replacement (TAVR). Overall, 92.9% years with a mean PROM of 1.92%.

article thumbnail

Lifelong risk of stroke after TAVR: Findings from SwissTAVI Registry

Cardiology Update

Within the realm of transcatheter aortic valve replacement (TAVR), stroke emerges as a recognized adverse event, manifesting at various stages during and after the procedure. Previous studies extensively delved into short-term incidence, trends, and clinical outcomes related to TAVR-associated stroke. female) were included. at 5 years.

TAVR 111
article thumbnail

Diffuse Subendocardial Ischemia on the ECG. Left main? 3-vessel disease? No!

Dr. Smith's ECG Blog

6,7 Surgical repair of AS, by either TAVR or SAVR, is the definitive treatment for this condition. Heart 2011; 97 : 838-843 [link] 14. It has been recommended as a bridge to surgery in those that are not candidates for surgery. 5 Unfortunately, availability is generally limited to major medical centers. J Am Coll Cardiol.